+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sciatica - Epidemiology Forecast To 2028

  • ID: 4855544
  • Report
  • November 2019
  • Region: Global
  • 86 pages
  • DelveInsight
1 of 2
‘Sciatica - Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Sciatica in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

Geography Covered
  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2017-2028

Sciatica Epidemiology

The Sciatica epidemiology division provides insights about historical and current patient pool and forecasted trend for all the seven major countries. The epidemiology data for Sciatica are studied through all possible division to give a better understanding of the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports, and views of key opinion leaders.

Sciatica Epidemiology Segmentation

The report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

The disease epidemiology covered in the report is segmented by:
  • Diagnosed Prevalence of Sciatica
  • Lumbar Disc Herniation Cases
  • Gender-specific Diagnosed Prevalence of Sciatica
  • Age-specific Diagnosed Prevalence
According to this research, the total diagnosed prevalent cases of Sciatica in the seven major markets were 26,761,073. Moreover, the total diagnosed prevalent cases of Sciatica in the US were 12,388,685 cases in 2017, out of which the total cases lumbar disc herniation in the US was 11,149,817 cases in 2017.

Report Scope
  • The report covers the detailed overview of Sciatica explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns.
  • The report provides insight about the historical and forecasted patient pool for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Sciatica.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology by type-specific cases and severity specific cases of Sciatica in the 7MM.
Key Strengths
  • 10-Year Forecast of Sciatica epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Sciatica
  • Prevalent Cases according to segmentation
Key Assessments
  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
Note: Product cover images may vary from those shown
2 of 2

1. Key Insights

2. Disease Background and Overview: Sciatica
2.1. Introduction
2.2. Difference between Sciatica and Lower Back Pain
2.3. Symptoms of Sciatica
2.4. Causes of Sciatica
2.4.1 Spinal Disc Herniation
2.4.2 Spinal Stenosis
2.4.3 Pregnancy
2.4.4 Piriformis syndrome
2.4.5 Osteoarthritis
2.4.6 Spondylosis and spondylolisthesis
2.4.7 Nondiscogenic causes
2.5. Pathophysiology of disk-related sciatica
2.5.1 Clinical observation
2.5.2 Physiologic Variants of Sciatica
2.6. Pathophysiological Mechanisms in Radicular Pain
2.6.1 Inflammatory mechanism
2.6.2 Immunological mechanism
2.6.3 Compressive mechanism
2.6.4 Lumbar spinal stenosis
2.6.5 Skeletal Causes of Radiculopathy
2.6.6 Lumbar bulging or herniated disc
2.7. Biomarkers for Sciatica
2.8. Diagnosis of sciatica
2.8.1 Indicators for sciatica
2.8.2 Imaging
2.8.3 Selective Nerve Root Block (SRNB)
2.9. Differential Diagnosis
2.10. Clinical Guidelines for the Diagnosis for Sciatica
2.10.1 Clinical guideline for diagnosis for General Practice
2.11. Diagnostic algorithm

3. Epidemiology and Patient Population: Key Findings
3.1 7MM Total Diagnosed Prevalent Patient Population of Sciatica

4. Country Wise-Epidemiology of Sciatica
4.1 United States
4.1.1 Assumptions and Rationale
4.1.2 Assumptions and Rationale
4.1.3 Sciatica Diagnosed Prevalence in the United States
4.1.4 Lumbar Disc Herniation Cases in the United States
4.1.5 Sciatica Gender-specific Diagnosed Prevalence in the United States
4.2 EU5 Countries
4.2.1 Assumptions and Rationale
4.3 Germany
4.3.1 Sciatica Diagnosed Prevalence in Germany
4.3.2 Lumbar Disc Herniation Cases in Germany
4.3.3 Sciatica Gender-specific Diagnosed Prevalence in Germany
4.3.4 Sciatica Age-specific Diagnosed Prevalence in Germany
4.4 France
4.4.1 Sciatica Diagnosed Prevalence in France
4.4.2 Lumbar Disc Herniation Cases in France
4.4.3 Sciatica Gender-specific Diagnosed Prevalence in France
4.4.4 Sciatica Age-specific Diagnosed Prevalence in France
4.5 Italy
4.5.1 Sciatica Diagnosed Prevalence in Italy
4.5.2 Lumbar Disc Herniation Cases in Italy
4.5.3 Sciatica Gender-specific Diagnosed Prevalence in Italy
4.5.4 Sciatica Age-specific Diagnosed Prevalence in Italy
4.6 Spain
4.6.1 Sciatica Diagnosed Prevalence in Spain
4.6.2 Lumbar Disc Herniation Cases of Sciatica in Spain
4.6.3 Sciatica Gender-specific Diagnosed Prevalence in Spain
4.6.4 Sciatica Age-specific Diagnosed Prevalence in Spain
4.7 United Kingdom
4.7.1 Sciatica Diagnosed Prevalence in the United Kingdom
4.7.2 Lumbar Disc Herniation Cases in the United Kingdom
4.7.3 Sciatica Gender-specific Diagnosed Prevalence in the United Kingdom
4.7.4 Sciatica Age-specific Diagnosed Prevalence in the United Kingdom
4.8 Japan
4.8.1 Assumptions and Rationale
4.8.2 Sciatica Diagnosed Prevalence in Japan
4.8.3 Lumbar Disc Herniation Cases in Japan
4.8.4 Sciatica Gender-specific Diagnosed Prevalence in Japan
4.8.5 Sciatica Age-specific Diagnosed Prevalence in Japan

5 Appendix
5.1 Report Methodology

6 Capabilities

7 Disclaimer

8 About the Publisher

List of Tables
Table 1: Nondiscogenic causes of sciatica
Table 2: Physiologic Variants of Sciatica
Table 3: Total Diagnosed Population of Sciatica in the 7MM (2017-2028)
Table 4: Sciatica Diagnosed Prevalence in the United States (2017-2028)
Table 5: Lumbar Disc Herniation in the United States (2017-2028)
Table 6: Sciatica Gender-specific Diagnosed Prevalence in the United States (2017-2028)
Table 7: Sciatica Age-specific Diagnosed Prevalence in the United States (2017-2028)
Table 8: Sciatica Diagnosed Prevalence in Germany (2017-2028)
Table 9: Lumbar Disc Herniation in Germany (2017-2028)
Table 10: Sciatica Gender-specific Diagnosed Prevalence in Germany (2017-2028)
Table 11: Sciatica Age-specific Diagnosed Prevalence in Germany (2017-2028)
Table 12: Sciatica Diagnosed Prevalence in France (2017-2028)
Table 13: Lumbar Disc Herniation Cases in France (2017-2028)
Table 14: Sciatica Gender-specific Diagnosed Prevalence in France (2017-2028)
Table 15: Sciatica Age-specific Diagnosed Prevalence in France (2017-2028)
Table 16: Sciatica Diagnosed Prevalence in Italy (2017-2028)
Table 17: Lumbar Disc Herniation in Italy (2017-2028)
Table 18: Sciatica Gender-specific Diagnosed Prevalence in Italy (2017-2028)
Table 19: Sciatica Age-specific Diagnosed Prevalence in Italy (2017-2028)
Table 20: Sciatica Diagnosed Prevalence in Spain (2017-2028)
Table 21: Lumbar Disc Herniation in Spain (2017-2028)
Table 22: Sciatica Gender-specific Diagnosed Prevalence in Spain (2017-2028)
Table 23: Sciatica Age-specific Diagnosed Prevalence in Spain (2017-2028)
Table 24: Sciatica Diagnosed Prevalence in the United Kingdom (2017-2028)
Table 25: Lumbar Disc Herniation in the United Kingdom (2017-2028)
Table 26: Sciatica Gender-specific Diagnosed Prevalence in the United Kingdom (2017-2028)
Table 27: Sciatica Age-specific Diagnosed Prevalence in the United Kingdom (2017-2028)
Table 28: Sciatica Diagnosed Prevalence in Japan (2017-2028)
Table 29: Lumbar Disc Herniation in Japan (2017-2028)
Table 30: Sciatica Gender-specific Diagnosed Prevalence in Japan (2017-2028)
Table 31: Sciatica Age-specific Diagnosed Prevalence in Japan (2017-2028)

List of Figures
Figure 1: Types of lumbar disc herniation classification based on the location of the disc herniation relative to the facet joint and spinal canal.
Figure 2: Piriformis Muscles Syndrome
Figure 3: Pathophysiological mechanisms in radicular pain.
Figure 4: Pathoanatomical Features of Degenerative Lumbar Spinal Stenosis.
Figure 5: Algorithm for the diagnostic evaluation of patients with low-back pain.
Figure 6: Total Diagnosed Patient Population of Sciatica in the 7MM (2017-2028)
Figure 7: Sciatica Diagnosed Prevalence in the United States (2017-2028)
Figure 8: Lumbar Disc Herniation Cases in the United States (2017-2028)
Figure 9: Sciatica Gender-specific Diagnosed Prevalence in the United States (2017-2028)
Figure 10: Sciatica Age-specific Diagnosed Prevalence in the United States (2017-2028)
Figure 11: Sciatica Diagnosed Prevalence in Germany (2017-2028)
Figure 12: Lumbar Disc Herniation Cases of Sciatica in Germany (2017-2028)
Figure 13: Sciatica Gender-specific Diagnosed Prevalence in Germany (2017-2028)
Figure 14: Sciatica Age-specific Diagnosed Prevalence in Germany (2017-2028)
Figure 15: Sciatica Diagnosed Prevalence in France (2017-2028)
Figure 16: Lumbar Disc Herniation in France (2017-2028)
Figure 17: Sciatica Gender-specific Diagnosed Prevalence in France (2017-2028)
Figure 18: Sciatica Age-specific Diagnosed Prevalence in France (2017-2028)
Figure 19: Diagnosed Prevalence of Sciatica in Italy (2017-2028)
Figure 20: Lumbar Disc Herniation in Italy (2017-2028)
Figure 21: Sciatica Gender-specific Diagnosed Prevalence in Italy (2017-2028)
Figure 22: Sciatica Age-specific Diagnosed Prevalence in Italy (2017-2028)
Figure 23: Sciatica Diagnosed Prevalence in Spain (2017-2028)
Figure 24: Lumbar Disc Herniation in Spain (2017-2028)
Figure 25: Sciatica Gender- specific Diagnosed Prevalence in Spain (2017-2028)
Figure 26: Sciatica Age-specific Diagnosed Prevalence in Spain (2017-2028)
Figure 27: Sciatica Diagnosed Prevalence in the United Kingdom (2017-2028)
Figure 28: Lumbar Disc Herniation in the United Kingdom (2017-2028)
Figure 29: Sciatica Gender-specific Diagnosed Prevalence in the United Kingdom (2017-2028)
Figure 30: Sciatica Age-specific Diagnosed Prevalence in the United Kingdom (2017-2028)
Figure 31: Sciatica Diagnosed Prevalence in Japan (2017-2028)
Figure 32: Lumbar Disc Herniation in Japan (2017-2028)
Figure 33: Sciatica Gender-specific Diagnosed Prevalence in Japan (2017-2028)
Figure 34: Sciatica Age-specific Diagnosed Prevalence in Japan (2017-2028)

Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll